US mRNA specialist Moderna has announced that the UK Court of Appeal has upheld the validity of its EP'949 patent.

For the first time in decades, the pharmaceutical industry has been directly affected by a geopolitical trade negotiation ...

US biotech major Biogen (Nasdaq: BIIB) reported a 7% rise in its second quarter revenue Friday, with sales of $2.45 billion.

US Biotech Regeneron Pharmaceuticals today announced financial results for the second quarter of 2025 and provided a business ...